Viberzi 100 mg/1
Eluxadoline · TABLET, FILM COATED · Allergan, Inc.
Viberzi is a tablet, film coated containing eluxadoline at 100 mg/1, taken oral. Manufactured by Allergan, Inc..
Key Facts
- Brand Name
- Viberzi
- Generic Name
- Eluxadoline
- NDC Code (Product)
61874-100- Manufacturer
- Allergan, Inc.
- Strength
- 100 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- DEA Schedule
- Schedule IV (Controlled)
- Application #
- NDA206940
- Drug Class
- mu-Opioid Receptor Agonist [EPC]
- Marketing Start
- 10/01/2015
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Viberzi used for?
Viberzi contains Eluxadoline. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Viberzi a controlled substance?
Yes, Viberzi is classified as CIV under the DEA Controlled Substances Act.
What is the generic name for Viberzi?
The generic name for Viberzi is Eluxadoline. There are no other listed brand versions of Eluxadoline.
What is the NDC code for Viberzi 100 mg/1?
The NDC (National Drug Code) for Viberzi 100 mg/1 is 61874-100, listed by Allergan, Inc..
Other Viberzi Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)